Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Nemaura Medical Inc
(NQ:
NMRD
)
0.1053
UNCHANGED
Last Price
Updated: 4:00 PM EST, Jan 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Nemaura Medical Inc
< Previous
1
2
3
4
5
Next >
Tesla, Ra Medical Systems And 51 Stocks Moving In Tuesday's Mid-Day Session
July 05, 2022
Gainers Ra Medical Systems, Inc. (NASDAQ: RMED) shares jumped 69.6% to $0.5240 after the company announced it has received FDA 510(k) clearance for its DABRA 2.0 catheter.
Via
Benzinga
Nemaura Medical's Return On Capital Employed Insights
July 01, 2022
Nemaura Medical (NASDAQ:NMRD) brought in sales totaling $320.28 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 5.41%, resulting in a loss of $3.62 million.
Via
Benzinga
Nemaura Medical: Q4 Earnings Insights
June 30, 2022
Nemaura Medical (NASDAQ:NMRD) reported its Q4 earnings results on Thursday, June 30, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Nemaura Marks History-Making Milestone With Initial Shipment Of CGM Devices
January 28, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
May 13, 2022
On Friday, 153 companies set new 52-week lows.
Via
Benzinga
Nemaura Medical's (NASDAQ: NMRD) Technologies Stand Distinct
April 04, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2022
March 29, 2022
Upgrades
Via
Benzinga
Nemaura To Participate At Maxim Group Virtual Growth Conference
March 25, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Nemaura Medical (NASDAQ: NMRD), a...
Via
Benzinga
Nemaura Medical Bringing Valuable AI-Powered Insights To Diabetes Market
March 23, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
Nemaura Enters Commercialization Phase Of Development
March 21, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
Nemaura Medical's sugarBEAT(R) CGM Device Met With Early Success
March 14, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Nemaura Medical (NASDAQ: NMRD), a...
Via
Benzinga
Nemaura Medical Recognized As Innovator Of The Year
March 01, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Nemaura Medical (NASDAQ: NMRD), a...
Via
Benzinga
Nemaura Medical Producing What Was Thought To Be Implausible
February 24, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Nemaura Medical (NASDAQ: NMRD) has long...
Via
Benzinga
Nemaura Reports Financial Results, Business Updates for Q3 2022
February 15, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
Nemaura Appoints New COO In Readiness For Manufacturing, Distribution Scale-Up
February 14, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Nemaura Medical (NASDAQ: NMRD) recently...
Via
Benzinga
Nemaura Set To Capitalize On Glucose Monitoring's Exponential Growth Rate
February 10, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. The blood glucose monitoring system sector is expected to grow...
Via
Benzinga
Nemaura Commences Rollout Of Miboko Application
February 04, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
Nemaura Medical Appoints Healthcare Specialist Dr. Arash Ghadar as COO
January 31, 2022
NMRD appoints UK-based Dr. Arash Ghadar as Chief Operating Officer, brings decades of healthcare and technology experience Dr. Ghadar previously supervised product development lifecycles, feasibility...
Via
Benzinga
Nemaura Medical Commences Rollout of Miboko Application
January 25, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Nemaura Medical is a medical technology...
Via
Benzinga
Nemaura Medical Firmly Positioned in Growing Diabetes Tech Market
January 21, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Diabetes tech market expanded in 2021...
Via
Benzinga
Nemaura Medical Launches Miboko – A New Metabolic Health Program
January 14, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Nemaura Medical (NASDAQ: NMRD), a...
Via
Benzinga
Nemaura Medical Names Industry Veteran as COO
January 11, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Nemaura Medical (NASDAQ: NMRD), a...
Via
Benzinga
Nemaura Medical to Present at H.C. Wainwright Bioconnect Conference
January 10, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Nemaura Medical (NASDAQ: NMRD), a...
Via
Benzinga
Nemaura Medical Solutions Empowering People to Take Charge of Well-Being
December 29, 2021
Nemaura Medical (NASDAQ: NMRD) is a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized...
Via
Benzinga
Nemaura Medical Complete Initial Shipment of sugarBEAT(R) Devices to UK Licensee
December 23, 2021
Nemaura Medical announced the successful completion of its initial shipment of sugarBEAT(R) continuous glucose monitor devices to its UK licensee The initial shipment, which...
Via
Benzinga
Nemaura Medical Positioned to Benefit from Growth in CGM Market
December 14, 2021
Nemaura Medical (NASDAQ: NMRD) has developed a platform to monitor multiple chemicals in the blood without needles, replacing traditional invasive methods of diagnosis and health...
Via
Benzinga
54 Biggest Movers From Yesterday
December 08, 2021
Gainers Siyata Mobile Inc. (NASDAQ: SYTA) shares jumped 66.7% to close at $4.60 on Tuesday. Siyata Mobile received $1.3 million purchase order for SD7 ruggedized devices and...
Via
Benzinga
Nemaura Medical Releases Q2-2021 Results, Signs Global Commercial Contract
December 02, 2021
NMRD releases fiscal Q2-2021 results, provides business update Highlights include pending revenue recognition, global commercial contract with MySugarWatch DuoPack Limited, the...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 2, 2021
December 02, 2021
Upgrades According to William Blair, the prior rating for Graco Inc (NYSE:
Via
Benzinga
Nemaura Medical CEO to Present at Upcoming Conference
December 01, 2021
Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.